Abstract
Introduction

Repair of large bone defects is still a challenge for the orthopaedic, reconstructive and maxillo-facial surgeon. Availability of pluripotent mesenchymal stem cells (MSCs) and the potential of inducing the osteogenic phenotype is motivating exploration and development of custom-tailored materials known as 'bioengineered bone constructs' [1]. In such cases, the clinical scenario involves either expansion of stem cells in monolayers and loading them into a porous scaffold prior to surgery or direct cell expansion within the scaffold, and implanting this novel construct back into the donor patient. Although clinical studies have been initiated
and encouraging results for the repair of long bones were obtained in large animals [6] [7] [8] [9] [10] 
, the therapeutic effectiveness of bone constructs has not yet met the one of autologous bone grafts (the benchmark of bone repair). The reasons for this limited osteogenic potential of bone constructs are not yet fully understood but massive death of transplanted cells after engraftment into the tissue-construct is a prime factor. Support for this implication is given by in vivo experiments in which massive cell death was observed when mesenchymal cells, loaded into scaffolds,
were implanted either subcutaneously [11] or into mouse calvarial bone defects [12] . Further evidence was provided by the in vivo delivery of a single suspension of MSCs for the treatment of either cardiac ischemia (reviewed in [13] ) or acute kidney injury in mice [14] . In [15] [16] [17] , it is reasonable to postulate that MSCs loaded into a scaffold and transplanted into a bone defect will experience the rigors of a hypoxic microenvironment. This hypothesis is supported by the finding that in vivo oxygen tension falls to 1% O2 at bone fracture sites [18, 19] and to [12] [13] [14] [15] [16] [17] [18] [19] [20] mmHg in the periosteal space adjacent to an osteotomy gap between days 6 and 10 after surgery [20] . However [22] . (Fig. 1B) . 
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Expression of HIF-1␣
Expression of the transcription factor HIF-1␣, a chemical essential to the response of cells to hypoxia, was assessed in MSCs cultured in either 21 or 1% O2. Whereas HIF-1␣ was always localize in the cytoplasm in MSCs cultured at 21% O2, it was systematically found in the nuclei of MSCs cultured in 1% O2 as early as 24 hrs after cell adhesion
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of HIF-1␣). (C) Time course of lactate production by sheep MSCs in normoxia (white bars) and hypoxia (black bars). (D) Time course of residual glucose in MSC cultures (per well) in normoxia (white circles) and hypoxia (black triangles). (E) Normalized (to day 0) fold increase of intracellular ATP in normoxia (white bars) and in hypoxia (black bars).
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Determination of glucose and ATP
Under the oxygen conditions tested, the kinetics of glucose consumption led to complete depletion of glucose between days 6 and 9 of culture (Fig. 1D) 
The fate of MSCs in the hypoxia/ischemia model
In a 21% O2 environment, MSCs retained their typical stellate morphology up to 6 days of culture but, when they reached confluence, they exhibited a cobblestone appearance for the remainder of the study, i.e. 12 days (Fig. 2A, Normoxia) . In contrast, in the 1% O2 environment, MSCs exhibited their typical stellate morphology up to day 6 but shrank progressively thereafter ( Fig. 2A,  Hypoxia) . Such reduction in cell size was documented by measuring the cell surface area (Fig. 2B, b) (Fig. 2B, a) . Under both oxygen-related conditions tested, an increase in viable cell number was observed at days 3 and 6 (Fig. 2C) (Fig. 2D) .
Taken together, these data establish that, under ischemic conditions (i.e. hypoxia combined with absence of glucose), the MSCs did not survive.
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Fig. 2 Viability of MSCs: in vitro model. (A) Morphology of MSCs either maintained in normoxia or exposed to hypoxia for 12 days. Stain: haematoxylin and eosin. Light microscopy magnification: ϫ20. (B) FACS analysis of cell size and area of MSCs either maintained in normoxia or exposed to hypoxia for 12 days. (C) Time course of cell viability when MSCs were either maintained in normoxia (white bars) or were exposed to hypoxia (black bars). (D) FACS analysis of apoptotic MSCs stained with annexin-V following either maintenance in normoxia (white bar); hypoxia (black bar) for 12 days or positive control in normoxia (striped bar)
. *P Ͻ 0.05 and **P Ͻ 0.001.
Respective role of continuous hypoxia and glucose supply in MSC survival
The death of MSCs cultured in a 1% O2 environment might be due to either a shortage of glucose or to the continuous exposure of MSCs to hypoxia. The effect of hypoxia per se on MSC survival was, therefore, first assessed in an experimental setting that prevented exposure of MSCs to glucose shortage (i.e. the MSCs were exposed to continuous hypoxia in serum-free conditions but to a medium that contained 1% glucose). Under such conditions, no shortage of glucose was observed during the 12 days of culture (Fig. 3B, b). Under these conditions, the MSCs retained their typical stellate morphology (Fig. 3A, Hypoxia/SD); during that time the MSCs produced lactate suggesting that they had shifted to anaerobic metabolism (data not shown). Interestingly, these
MSCs remained quiescent for up to 6 days of culture but proliferated thereafter (Fig. 3B, a) (Fig. 3C, b) . During that time, the MSCs retained their typical stellate morphology (Fig. 3A , Hypoxia/HG) and proliferated for up to 6 days of culture; at that time cell proliferation reached a plateau (Fig. 3C, a) to an ischemic episode or maintained under standard cell culture conditions were similar (Fig. 4D ).
In vitro assessment of MSC function after ischemia
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Discussion
The 
C) Representative histology results of MSC-containing constructs after 2 months of subcutaneous implantation in mice: (a) Transplanted implant without MSCs, (b) transplanted implant with MSCs cultured in normoxia and (c) transplanted implant with MSCs cultured in hypoxia/SD (including magnification of new formed bone also delineated by doted black lines for quantification), before implantation. Stain: Stevenel Blue and von Gieson picro-fuchsin (bone); (magnification: ϫ2). (d) Magnification (ϫ20) of new formed bone with osteocytes and lacunae (arrows). (D) New bone quantification in MSCcontaining constructs after 2 months of subcutaneous implantation in mice (normalized with respect to control scaffolds without MSCs).
critical because brief duration exposures to hypoxia may protect cells from lethal injury [28] . Last, but not least, the present model is physiologically relevant because it exposed cells not only to continuous hypoxia but also to oxygen tension levels which are similar to the ones observed in vivo (i.e. 1 to 3% O2) [18] [19] [20] .
Hypoxia is a pathological condition in which oxygen demand by cells exceeds supply [30] . As Fig. 2A and B) , number of viable cells (Fig. 2C) and ATP content per cell (Fig. 1E) (Fig. 3B, a) (Fig. 3C, a) [37] [39] .
In vivo, under ischemic conditions, MSCs experienced not only hypoxia but also reduced supply of critical metabolic nutrients and inadequate metabolic waste removal (for review, see [40] 
